Pharmaceutical News

RSS

Starpharma launches new start-up biotechnology company

Starpharma Holdings Limited today announced the establishment of a start-up biotechnology company (as a foundation shareholder).

15 Mar 2005

ID Biomedical pursues accelerated approval of influenza vaccine

ID Biomedical Corporation announced today that it has been advised by the United States Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) that the Company's injectable influenza vaccine is eligible for accelerated approval and priority review mechanisms, allowing possible licensure of the vaccine in time to manufacture product for the 2006/07 season.

15 Mar 2005

Decision to cut Alzheimer's drugs challenged

Four major drugs, the only drugs licensed in Britain for the treatment of Alzheimer's disease and available on the NHS may be withdrawn. Aricept, Exelon, Reminyl and Ebixa are the only drugs licensed in Britain for the treatment of the disease.

14 Mar 2005

New hepatitis drug wins approval by FDA

An experimental hepatitis B drug has earned the praise of US health experts for its effectiveness and has been recommended by the US Food and Drug Administration (FDA) advisory panel to treat the liver disease in adults.

14 Mar 2005

2004 FDA drug complaints way up high

The Food and Drug Administration (FDA) received a record number of complaints regarding drug side effects and other related health problems in 2004, according to a published report.

14 Mar 2005

New biocentre which will revolutionise the way future medicines are produced

The University of Manchester has been awarded £6m to open a new biocentre which will revolutionise the way future medicines are produced – making them safer and more effective.

From The University of Manchester 14 Mar 2005

New H5N1 avian influenza vaccine

Merial today announced the introduction of a new inactivated vaccine, GALLIMUNE Flu H5N9, developed and shown to be effective specifically for use against the highly pathogenic avian influenza virus H5N1 that has caused devastating economic losses in the poultry industry in Asia, and which has been linked to the deaths of over 29 humans.

14 Mar 2005

Protopic and Elidel may cause cancer

Protopic and Elidel, two treatments for eczema approved in 2000 and 2001, have now been found to cause cancer in three different animal species.

13 Mar 2005

New flu vaccine for kids hits the market

A new pediatric influenza vaccine that contains no preservatives - the only influenza vaccine approved for use in children 6 to 35 months of age - has been produced by the sanofi-aventis Group, in time for the 2005-2006 influenza season.

10 Mar 2005

FDA seizes drug orders from overseas

The U.S. Food and Drug Administration has seized prescription drug orders shipped from abroad to more than 50 customers of I-Save-R-x, a program launched last year by Governor Rod Blagojevich, to help residents save money on prescription drugs.

10 Mar 2005

New MS drug withdrawn from the market

Two patients involved in clinical trials of Tysabri, have contracted a rare and fatal disease, Elan’s multiple sclerosis (MS); one has already died. Withdrawal of the drug, eliminates all hope that it will be allowed back on the market this year, or ever.

8 Mar 2005

Thalidomide - new treatment for cancer

Thalidomide, famous in the 60's because of limb deformities in babies born to women who had taken it for morning sickness, was withdrawn in 1961. Now doctors say it could be used as a treatment for cancer.

8 Mar 2005

Web site offers fast access to drugs

A new web site run by pharmaceutical companies can help direct Indiana residents to prescription drug programs that offer free or discounted medications. Governor Mitch Daniels, a former executive at Eli Lilly and Company, says it's a safer alternative to importing drugs from other countries.

8 Mar 2005

Biomedical engineers, chemists collaborate on novel method to design better medicines

The ability to select and develop compounds that act on specific cellular targets has just gained a computational ally -- a mathematical algorithm that predicts the precise effects a given compound will have on a cell's molecular components or chemical processes.

8 Mar 2005

U.S Marshals action affects Glaxo share price

Early this month, U.S. marshals seized batches of Paxil CR and Avandamet at manufacturing and distribution sites in Puerto Rico and Knoxville, Tennessee.

8 Mar 2005

AIDS drug pricing complaint in South Africa against GlaxoSmithKline moves forward

A landmark South African legal complaint against British drug maker GlaxoSmithKline (GSK) over its AIDS drug pricing and policies in that country will proceed following an order late last week by South Africa's Competition Tribunal that will allow the complaint to go forward.

8 Mar 2005

Nano-enabled drug discovery solutions will generate revenues of $1.3 billion in 2009

According to a new report by NanoMarkets, an industry consultancy based here, nano-enabled drug discovery solutions will generate revenues of $1.3 billion in 2009 and grow to $2.5 billion in 2012.

8 Mar 2005

Cymbalta improves cognitive function in elderly patients with depression

Elderly patients with depression treated with Cymbalta (duloxetine hydrochloride), 60 mg once daily, had twice as much improvement in verbal learning and recalling information than those given a sugar pill, according to new research presented Saturday at the annual meeting of the American Association for Geriatric Psychiatry.

8 Mar 2005

Revlimid results look promising for multiple myeloma patients

The Multiple Myeloma Research Foundation (MMRF) applauded today's Celgene announcement regarding Revlimid, a new class of novel immunomodulatory drugs currently being evaluated to treat a broad range of hematology and oncology conditions, including multiple myeloma.

8 Mar 2005

Battle in the Senate over FDA

In the congressional battle over the safety of America's prescription drugs, two University of Washington experts with opposing views have been enlisted into the fray.

7 Mar 2005